Panel Discussion: FDA’s Risk Management of AI

Presented by: Moderator: Chinmoy Roy, Senior Industry Consultant, ValGenesisPanelists: Rosalind Beasley, Chief Executive Officer, Main and Mission Inc.Roy Devine, Global Process Owner Computer System Validation, BDDaniel Walter, Policy Analyst, CDRH, U.S. FDA

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

You must log in to view this content.

Presented by: Moderator: Chinmoy Roy, Senior Industry Consultant, ValGenesisPanelists: Rosalind Beasley, Chief Executive Officer, Main and Mission Inc.Roy Devine, Global Process Owner Computer System Validation, BDDaniel Walter, Policy Analyst, CDRH, U.S. FDA

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

Presented by:

,

Conference Sessions, CSV/CSA

Become a Member to View this Content

Please provide your information below

Recommended for you

Case Study: Transitioning from Paper to Digitally Successfully

Digital CQV and Pharma 4.0: Paving the Way for Future Success

More resources